Schedules of controlled substances: Correction,

[Federal Register: March 28, 2002 (Volume 67, Number 60)]

[CORRECTIONS]

[Page 15011]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr28mr02-147]

DEPARTMENT OF JUSTICE

Drug Enforcement Agency

21 CFR Part 1308

[DEA-225P]

Schedule of Controlled Substances: Proposed Rule: Rescheduling of Buprenorphine From Schedule V to Schedule III

Correction

In proposed rule document 02-6767beginning on page 13114 in the issue of Thursday, March 21, 2002, make the following corrections:

1. On page 1135, in the first column, in the second paragraph, in the first line, ``(0.3mg/m1)'' should read, ``(0.3mg/ml)''.

2. On the same page, in the first column, in the second paragraph, in the fifth line, ``Subozone'' should read, ``Suboxone''.

3. On the same page, in the second column, in the second paragraph, in the thirteenth line, ``table'' should read, ``tablet''.

4. On the same page, in the same column, in the second paragraph, in the 15th line, ``fewer'' should read, ``newer''.

5. On page 13115, under the heading ``What Is the Effect of This Notice?'', in the first paragraph, in the fourth line, ``salts or '' should read, `` salts of''.

[FR Doc. C2-6767Filed3-27-02; 8:45 am]

BILLING CODE 1505-01-D